World Endometriosis Congress - New diagnostic test showcased
Filed with ASX · · 4 pages · English
• Proteomics International presents potential new blood test for endometriosis at the 15th World Congress on Endometriosis in Edinburgh, Scotland, held by the World Endometriosis Society • Test offers improved early screening for the disease, correctly identifying up to 90 per cent of patients with the condition in a study of over 900 participants • Research also suggests the current gold standard
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Canagliflozin lowers PromarkerD DKD risk prediction scores
- March 2023 Quarterly Activities Report and Appendix 4C
- Proteomics renews ISO 13485 and ISO 17025 accreditations
- New endometriosis test presented at international conference
- PromarkerD application for Australian MBS to be resubmitted
Later from Proteomics International Laboratories
- Sonic Healthcare USA signs licence for PromarkerD in the US
- June 2023 Quarterly Activities Report and Appendix 4C
- OxiDx platform technology secures patent in Japan
- New oesophageal cancer test presented at global conference
- Suspension from Quotation
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories